Aberrant expressions of self-renewal gene HIWI and microRNA let-7a are in epithelial 2 ovarian cancer (EOC). A U-shape association between HIWI expression and overall 3 survival is seen in several human cancers but unknown in EOC. HIWI physically binds 4 let-7a, but the clinical relevance of this interaction is yet to be addressed. Here we 5
Introduction 1
HIWI (also known as piwi-like RNA-mediated gene silencing 1, PIWIL1), located on 2 chromosome 12q14.33, is a member of the P-element induced wimpy testis (PIWI) gene 3 family in humans [1] . This family is evolutionarily conserved across species; their 4 encoded-proteins are highly homologous, particularly in the carboxy-terminus [1] . The 5 HIWI is a ribonucleoprotein in the length of 861 amino acids, which contains a N-6 terminal PIWI/Argonaute/Zwille (PAZ) domain and a PIWI domain at the carboxy-7 terminus [2-4]. The PAZ domain binds to single-stranded small RNA, and the PIWI 8 domain functions as an RNase H endonuclease cleaving target RNA complementarily 9 bound to small RNA [4] [5] [6] . The involvement of HIWI proteins in the regulation of gene 10 expression is through their interacting partners of small non-coding RNAs such as 11 namely PIWI-associated RNAs (piRNAs) [7] . Nuclear HIWI controls retrotransposon 12 silencing via affecting DNA methylation [8] [9] [10] . Recently, Sequencing results of 13 Immunoprecipitation (IP) against HIWI show that HIWI interacts with miRNAs 14 including let-7a in fining gene expression [11] . Moreover, it has also been reported that 15 HIWI can be a partner interacting with Dicer, a key RNase III endonuclease in miRNA 16 maturation [12] [13] [14] . These findings suggest HIWI is also localized in cytoplasm and 17 may participate in the role of miRNAs in gene regulation. The HIWI gene is expressed 18 in hematopoietic stem cells and germ cells but not in differentiated cells. It has been 19 evidenced that HIWI plays an important role in maintaining stem cell renewal 20 [1, 7, 15, 16] . In the PIWI mutant models, germline stem cell asymmetric divisions cannot 21 be functionally processed in both male and female flies, leading to a loss of germline 22 stem cells and a reduced number of eggs and sperms during oogenesis or 23
MicroRNA let-7a is one member of let-7 family, which is one well-characterized 1 miRNA in controlling gene expression, and plays important roles in cell proliferation, 2 differentiation, apoptosis and metabolism [28] [29] [30] . Dysregulated let-7a has been 3 reported in different types of human cancer [31] [32] [33] [34] , and associates with cell 4 proliferation, chemotherapy response, and patient survival [35] [36] [37] . Moreover, the 5 involvement of let-7a has been demonstrated in stemness [38] [39] [40] . Our previous study 6 also showed that let-7a was associated with epithelial ovarian cancer survival [37] . 7
Given that cytoplasmic HIWI protein can interact with let-7a directly [11] or indirectly 8 through miRNA maturation-associated protein Dicer, which could form a negative 9 feedback loop with let-7a [41] , and that both HIWI and let-7a are involved in the 10 maintenance of stem cells [1, 7, 15, 16 ,42], we speculate that HIWI and let-7a may 11 orchestrate in executing biological functions. Thus, the purposes of this study were to 12 determine HIWI expression and its interaction with let-7a in the prognosis of epithelial 13 ovarian cancer. 14 15
Materials and Methods 16

Patients and tumor samples 17
In this study, a written informed consent was obtained from each individual of the 18 participants, and all subjects in this study were de-identified for the sake of participants' 19 privacy. With the approval of the University's ethical review committee, 211 women 20 diagnosed with epithelial ovarian cancer were enrolled between October 1991 and 21 (maximum and minimum) of all measurable lesions without the development of new 10 lesions for at least a month, (c) stable disease: a decrease of <50% or an increase of 11 <25% in the product of the diameters of all measurable lesion, and (d) progressive 12 disease: an increase of ≥25% in the product of the diameters of all measurable lesions or 13 the development of new lesions. Of the 176 patients with available information on 14 chemotherapy treatment response, 128 (72.7%) who had complete response was 15 considered 'Yes' response in data analysis, while 48 (27.3%) who were in the other 16 three categories were grouped as 'No' response, which included 36 with partial 17 response, 4 with stable disease, and 8 with progressive disease. 18
19
Analysis of HIWI and let-7a expression 20
All tumor samples were examined by two independent pathologists, and the specimens 21 which contained 80-90% tumor cells were used in this study. Total RNAs extracted 22 from the tumor samples were used as templates to make cDNA using the Cloned AMV 23 and each pair of primers, at final concentrations of 100 nM for both HIWI and RNU48. 11 PCR amplification included initial incubation at 50°C for 2 minutes, denaturing at 95°C 12 for 10 minutes, and 40 cycles of denaturing at 95°C for 15 seconds and annealing at 13 60°C for one minute. Melting curves were analyzed after each run to verify the size of 14 PCR product. 15 Analysis of let-7a expression in tumor tissue was performed using Taqman ® microRNA 16 assay (Applied Biosystems), in which the preparation of miRNA cDNA was made first 17 using a stem-loop method, following the manufacturer's instruction as described in our 18 previous report [45] . Briefly, levels of let-7a and RNU48 (an internal control for 19 normalization) expression in the samples were determined with the Taqman ® miRNA 20 assay (Applied Biosystems) using the Chromo4 Real-time PCR System. In the PCR 21 reaction (15 µl), 0.3 µl of cDNA template was mixed with 7.5 µl of 2×Taqman® 22
Universal PCR master mix (Applied Biosystems), 0. were grouped into 3 categories, low, medium and high, which were classified as 10 undetectable expression, detectable expression below median and detectable expression 11 equal to or above median, respectively. Let-7a was classified into two groups, low and 12 high, based on the median of let-7a expression distribution as the cutoff when the 13 interaction analysis was performed. Associations between HIWI expression and 14 clinicopathologic factors were analyzed by Chi-square statistic or Fisher's exact statistic 15 as appropriate. Survival analysis was performed to assess associations of HIWI 16 expression with risks of disease progression and death. Cox proportional hazards 17 regression and Kaplan-Meier survival curves were employed for the survival analyses. 18
Proportional hazards assumption was also tested in Cox proportional hazards 19 regression. All statistical analyses were performed using SAS version 9.2 (SAS 20
Institute, Cary, NC). All p-values are two-sided. Significant values are shown in bold. 21 22 23
Results
2
Clinical and pathological characteristics of patients 3
Clinical and pathological features of the 211 participants enrolled in this study were 4 shown in Table 1 HIWI had worse response to chemotherapy than those with either low or high 14 expression. The odds ratio (OR) was 3.01 (95% CI: 1.50 -6.04) ( We next sought to how HIWI and let-7a modulate each other the effect on patient 17 survival using stratification analyses (Table 5) . When we stratified patients by HIWI 18 expression levels, we did not find the associations of let-7a expression with overall 19 survival (p > 0.05) within the strata of either low/high or medium HIWI. In contrast, 20 when we stratified patients by let-7a expression levels (low and high), we found among 21 patients with high let-7a expression, medium expression of HIWI significantly 22 increased the risk of death compared to low/high HIWI expression; the adjusted HR was We also investigated the association of HIWI expression in epithelial ovarian cancer 16 survival. We found that ovarian cancer patients with medium expression of HIWI had 17 shorter overall survival in comparison to those with low or high expression. This 18 association was independent of clinical or pathologic factors of the disease. We also 19 found that patients with medium levels of HIWI expression had poor response to 20 chemotherapy compared to those with low or high expression. To our knowledge, this is 21 the first study to examine self-renewal-associated gene HIWI expression and survival of 22 patients with epithelial ovarian cancer in a clinical setting. Our study showed that 23 patients with low or high HIWI expression had a more favorable prognosis. This finding 1 was similar to, but in the opposite direction of, observations of several previous clinical 2 studies, which showed that compared to medium, high or low HIWI expression was 3 associated with elevated death risks in patients with soft-tissue sarcoma and male 4 patients with pancreatic cancer [21-23]. Our result, however, seems to be more 5 consistent with findings of a very recent report, in which it was shown that significantly 6 increased HIWI expression was observed in epithelial ovarian cancer compared to 7 normal ovarian tissues and benign tumor tissues, while enforced overexpression of 8 Only at high let-7a levels did patients with medium HIWI expression increase the risk of 21 death. This finding supports and extends the previous observation reported by Chen 22 and colleagues [11] , suggesting that HIWI protein not only physically binds let-7a, but 23 also orchestrate each other, executing their biological functions. This also may help to 1 explain the finding that cytoplasmic but not nuclear HIWI positively associated with 2 poor prognosis of esophageal squamous carcinoma [27] . 3
As expected, we found disease stage and residual tumor size, two well-established 4 prognostic risk factors, were unfavorable prognostic indicators, while chemotherapy 5 treatment improved survival. These results suggest that the findings in this study were 6 not observed by chance. 7 8 In summary, our study showed that self-renewal gene HIWI was associated with overall 9 survival as well as chemotherapy response in a U-shape correlation in epithelial ovarian 10 cancer. Taken together with the recent findings reported by Lim and colleagues [18] , 11 HIWI expression at a moderate level may associate with the increased risk of death and 12 poor chemotherapy response in epithelial ovarian cancer. We also found the synergetic 13 effect of self-renewal gene HIWI and miRNA let-7a on patient survival of epithelial 14 ovarian cancer. These findings suggest that the interplay between self-renewal gene 15 HIWI and miRNA let-7a has significant clinical relevance in epithelial ovarian cancer 16 prognosis, and reveal a potential strategy by the modulation of HIWI and let-7a in the 17 management of epithelial ovarian cancer. 18
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